Chandler Park, Advisory Dean and Clinical Professor at the University of Louisville School of Medicine, shared a post on LinkedIn:
“Loved joining my good friend Dr. Muhamed Baljevic from Vanderbilt-Ingram Cancer on stage as we discussed the new FDA-approved perioperative chemoimmunotherapy treatment that improves the cure rate for our bladder cancer patients at Cardinal Health Clinical Updates and Healthcare in Atlanta. It is a grear honor to have been one of the co-prinicipal investigators for this practice changing clinical study that becomes the new standard of care.”
More posts featuring Chandler Park.